维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="HASENCLEVER D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Role of urokinasetype plasminogen activator (uPA)and plasminogen activator inhibitor type1 (PAI-1)for prognosis in endometrial cancer显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol Oncol2008，108，：	1
2	Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol Oncol2008，108，3：	1
3	A prognostic score for advanced Hodgkin's disease 显示文摘	Hasenclever D Diehl V	1998	N Engl J Med1998，339，21：	1
4	BEACOPP, a new dose -escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced- stage Hodgkin's lympho- ma: interim report from atrial of the German Hodgkin's Lymphoma Study Group显示文摘	DIEHL V FRANKLIN J HASENCLEVER D	1998	J Clin Oncol1998，16，12：	1
5	Safety of AlloPBPCT donors: biomet- rical considerations on monitoring long term risks 显示文摘	Hasenclever D Sextro M	1996	Bone Marrow Transplant1996，2，：	1
6	StandardInternational Prognostic Index remains a valid predictor ofoutcome for patients with aggressive CD20 - B-celllymphoma in the rituximab era 显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，14：	1
7	A prognostic score for advanced Hodgkin~ disease显示文摘	Hasenclever D Diehl V Armitage JO	1998	New Eng J Med1998，339，21：	1
8	Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 ( PAI-1 ) for prognosis in endometrial cancer 显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol 0ncol2008，108，3：	1
9	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation 显示文摘	Schmitz N Bacigalupo A Hasenclever D	1998	Bone Marrow Transplant1998，21，10：	1
10	Role of the progesterone receptor for paclitaxel resistance in primary breast cancer显示文摘	Schmidt M Bremer E Hasenclever D	2007	Br J Cancer2007，96，2：	1
11	Role of the progesterone receptor for paclitaxel resistance in primary breast cancer显示文摘	SCHMIDT M BREMER E HASENCLEVER D	2007	Br J Cancer2007，96，2：	1
12	ErbB 3 predicts survival in ovarian cancer显示文摘	Tanner B Hasenclever D Stern K	2006	J Clin Oncol2006，24，：	1
13	The disappearance of prognostic factors in Hodgkin' s disease显示文摘	HASENCLEVER D	2002	Ann Oncol2002，13，1：	1
14	Standard International prognostic index remains a valid predictor of outcome for patients with aggressiveCD20+B-cell lymphoma in the rituximab era显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，14：	1
15	Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+B-cell lymphoma in the rituximab era显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，：	1
16	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia:first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation显示文摘	Schmitz N Bacigalupo A Hasenclever D	1998	Bone Marrow Transplant1998，21，10：	1
17	ErbB-3 pre-dicts survival in ovarian cancer显示文摘	Tanner B Hasenclever D Stern K	2006	J Clin Oncol2006，24，：	1
18	Standard International prognostic index remains a valid predictor of oulcome for patients with aggressive CD20 B-cell lymphoma in the rituximab era显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oneol2010，28，14：	1
19	Standard In- ternatonal prognostic index remains a valid predictor of outcome for patients with aggressive CD2o+ B-cell lym- phoma in the rituximab era 显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin 0ncol2010，28，14：	1
20	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia:first result of a randomised multicentre trial of European Group for Blood and MarrowTransplantation显示文摘	Schmitz N Bacigalupo A Hasenclever D	1998	Bone Marrow Transplant1998，21，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示